This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
February 21, 2012 8:00 am ET
Jeff Warren -
Omar S. Ishrak - Chairman and Chief Executive Officer
Gary L. Ellis - Chief Financial Officer, Principal Accounting Officer and Senior Vice President
Matthew J. Dodds - Citigroup Inc, Research Division
Robert A. Hopkins - Bank of America Corporation
David R. Lewis - Morgan Stanley, Research Division
Michael N. Weinstein - JP Morgan Chase & Co, Research Division
Kristen M. Stewart - Deutsche Bank AG, Research Division
David H. Roman - Goldman Sachs Group Inc., Research Division
Larry Biegelsen - Wells Fargo Securities, LLC, Research Division
Adam T. Feinstein - Barclays Capital, Research Division
Sara Michelmore - Brean Murray, Carret & Co., LLC, Research Division
Joanne K. Wuensch - BMO Capital Markets U.S.
Good morning. My name is Christie, and I will be your conference operator today. At this time, I would like to welcome everyone to the Medtronic's Third Quarter Earnings Release Conference Call. [Operator Instructions] Thank you. I would now like to hand the program over to Jeff Warren, Vice President, Investor Relations. Please go ahead.
Thank you, Christie. Good morning and welcome to Medtronic's Third Quarter Conference Call and Webcast. During the next hour, Omar Ishrak, Medtronic Chairman and Chief Executive Officer; and Gary Ellis, Medtronic Chief Financial Officer, will provide comments on the results of our fiscal year 2012 third quarter which ended January 27, 2012. After our prepared remarks, we'll be happy to take your questions.
First, a few logistical comments. Earlier this morning, we issued a press release containing our financial statements and a revenue-by-business summary. You should also note that some of the statements made during this call may be considered forward-looking statements and that actual results might differ materially from those projected in any forward-looking statement. Additional information concerning factors that could cause actual results to differ is contained in our periodic reports filed with the SEC. Therefore, we do not undertake to update any forward-looking statement. In addition, the reconciliations of any non-GAAP financial measures are available on the Investor's portion of our website at medtronic.com.